Cantor Fitzgerald reissued their overweight rating on shares of Aziyo Biologics (NASDAQ:AZYO – Free Report) in a report released on Tuesday morning, Benzinga reports. They currently have a $8.00 target price on the stock. Cantor Fitzgerald also issued estimates for Aziyo Biologics’ FY2023 earnings at ($2.13) EPS and FY2024 earnings at ($1.43) EPS. Aziyo Biologics […]
Aziyo Biologics (NASDAQ:AZYO – Get Free Report)‘s stock had its “overweight” rating reiterated by Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. They currently have a $8.00 price target on the stock. Cantor Fitzgerald’s price target suggests a potential upside of 430.82% from the company’s current price. Cantor Fitzgerald also issued estimates […]